During the past decade, Shonan Kamakura General Hospital conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 27 clinical trials were completed, i.e. on average, 67.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shonan Kamakura General Hospital" #1 sponsor was "Boston Scientific Corporation" with 10 trials, followed by "Abbott Medical Devices" with 7 trials sponsored, "Bayer" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shonan Kamakura General Hospital" #1 collaborator was "ICON plc" with 2 trials as a collaborator, "NPO International TRI Network" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Asahi Intech" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Shonan Kamakura General Hospital" are "Coronary Artery Disease" (14 trials), "Myocardial Ischemia" (6 trials), "Aortic Valve Stenosis" (5 trials), "Atrial Fibrillation" (4 trials) and "Coronary Disease" (4 trials). Many other conditions were trialed in "Shonan Kamakura General Hospital" in a lesser frequency.

Most popular intervention types in "Shonan Kamakura General Hospital" are "Device" (35 trials), "Drug" (23 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PROMUS Element Coronary Stent System" (3 trials), "Aspirin" (2 trials), "Daratumumab" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shonan Kamakura General Hospital" are 58 trials for "All" genders.

Currently, there are NaN active trials in "Shonan Kamakura General Hospital". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Shonan Kamakura General Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Shonan Kamakura General Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 23 trials that are defined as “Not Applicable".